Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • PrimeView
  • Published:

Systemic immunoglobulin light chain amyloidosis

Nature Reviews Disease Primers volume 4, Article number: 39 (2018) Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

This PrimeView highlights disease mechanisms and management strategies for systemic immunoglobulin light chain amyloidosis, which is a disease characterized by the tissue accumulation of amyloid fibrillar aggregates and organ dysfunction.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Systemic immunoglobulin light chain amyloidosis. Nat Rev Dis Primers 4, 39 (2018). https://doi.org/10.1038/s41572-018-0040-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41572-018-0040-5

Search

Advanced search

Quick links